Pharmerit (Netherlands)

Recent papers from Pharmerit (Netherlands)

1. Challenges and opportunities of adding CFTR modulators for cystic fibrosis to the WHO essential medicines listJournal of Cystic Fibrosis · 2025
2. A US Survey Across Seven Early-Stage Cancers Assessing the Humanistic Burden of Recurrence on Patients and CaregiversOncology and Therapy · 2025
3. Impact of recurrence on employment, finances, and productivity for early-stage cancer patients and caregivers: US surveyFuture Oncology · 2024
4. Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health statesThe European Journal of Health Economics · 2021
5. A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in FrancePLoS ONE · 2021
6. 2-Year Real-World Outcomes with Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: Literature Review and Meta-analysis of Patient-Relevant OutcomesOphthalmology and Therapy · 2021
7. Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysisBMC Infectious Diseases · 2021
8. Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in SpainJournal of Medical Economics · 2021
9. Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial FibrillationJournal of Clinical Medicine · 2020
10. Health State Utilities of Patients with Heart Failure: A Systematic Literature ReviewPharmacoEconomics · 2020
11. A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)PharmacoEconomics · 2020
12. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systemsBMC Ophthalmology · 2020
13. Systematic Literature Review of Randomized Trials Comparing Antithrombotic Therapy Following Revascularization Procedures in Patients With Peripheral Artery DiseaseAngiology · 2020
14. Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart reviewENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2020
15. Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature reviewBMC Pulmonary Medicine · 2020
16. Desirability and acceptability of a treatment-sequencing model in relapsing-remitting multiple sclerosis: A health technology assessment perspectiveInternational Journal of Technology Assessment in Health Care · 2020
17. Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and SwitzerlandLeukemia Research · 2020
18. Cost–effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the USJournal of Comparative Effectiveness Research · 2020
19. Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic ReviewPharmacoEconomics · 2019
20. A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature reviewPLoS ONE · 2019